2024 EAU/ESPU paediatric urology guidelines: key updates on congenital lower urinary tract obstruction and clinical inter-pretation.
10.3724/zdxbyxb-2025-0413
- Author:
Lingli MEI
1
;
Zhihui ZHENG
2
;
Chang TAO
3
;
Guangjie CHEN
3
;
Xiang YAN
3
Author Information
1. Department of Urology, Children's Hospital, Zhejiang University School of Medicine, Hangzhou 310052, China. 2766352787@qq.com.
2. Department of Urology, Children's Hospital, Zhejiang University School of Medicine, Hangzhou 310052, China. chzzh@zju.edu.cn.
3. Department of Urology, Children's Hospital, Zhejiang University School of Medicine, Hangzhou 310052, China.
- Publication Type:English Abstract
- Keywords:
Child;
Congenital lower urinary tract obstruction;
Guideline interpretation;
Management;
Posterior urethral valve
- MeSH:
Humans;
Urology;
Female;
Urethral Obstruction/therapy*;
Pregnancy;
Child;
Europe;
Prenatal Diagnosis;
Infant, Newborn;
Urethra/abnormalities*
- From:
Journal of Zhejiang University. Medical sciences
2025;54(5):583-591
- CountryChina
- Language:Chinese
-
Abstract:
Congenital lower urinary tract obstruction (CLUTO) is a spectrum of fetal malformations caused by anatomical abnormalities of the urethra, characterized by high rates of perinatal complications and mortality. The 2024 joint guideline from the European Association of Urology (EAU) and the European Society for Paediatric Urology (ESPU) introduced systematic revisions to the comprehensive management of CLUTO. Key updates encompass advancements in prenatal and postnatal screening and precise diagnosis, refined fetal prognosis assessment, clearer indications and modality selection for prenatal intervention, optimization of postnatal treatment strategies, and the establishment of a lifelong follow-up framework within an integrated care pathway. This article elucidates these key updates by comparing the 2024 EAU/ESPU guideline with the 2022 European Rare Kidney Disease Reference Network (ERKNet) consensus. It also discusses ongoing controversies and future research directions. The aim is to provide clinicians with the latest evidence-based insights to inform practice, ultimately improving outcomes and quality of life for children with CLUTO.
